Endocrine Abstracts

Growth hormone (GH) has profound anabolic effects on bone, but its use as a treatment for patients with osteoporosis has only resulted in small increases in BMD. The low serum IGF-I demonstrated in men with idiopathic osteoporosis may be important in the aetiology of this disease and has been attributed to GH hypo-secretion, though there are conflicting reports of this. Insensitivity to the actions of GH has also been suggested. We studied the GH-IGF-I axis in otherwise health...

Objective. Recent studies suggest that in utero programming of the hypothalamo-pituitary-adrenal axis is important in explaining the link between small size at birth and adult cardiovascular disease. We therefore examined the relationship between adult cortisol concentration and measurements at birth.Subjects. 420 men and women (mean age 69.5, range 65.0-75.8 yrs) born and living in Helsinki, Finland, with detailed birth records.<p class="ab...

Zoledronate in the Prevention of Paget’s disease (ZiPP) trial (ClinicalTrials.gov ID:NCT03859895) is a multi-centre, double-blind, placebo-controlled, randomised trial of Zoledronic acid (ZA) in sequestosome1 (SQSTM1) mutation carriers. SQSTM1 mutation has high penetrance and is associated with the early onset of Paget’s disease of bone. Participants with the SQSTM1 genotype received either a single dose of IV 5mg ZA (Aclasta, Novartis); intervention group n...

Background: Incorporating the ideas and views of children and young people (CYP) with endocrine conditions from early stages in the research life cycle will increase the benefit for patients and contribute to high impact research.Methods: We conducted two days of patient and public involvement (PPI) sessions with patients from a tertiary endocrine centre who are living with Congenital Adrenal Hypoplasia (CAH). We explore...

Introduction: Steroids can precipitate significant hyperglycemia and Diabetes Mellitus in vulnerable populations including DM, pre-DM and the elderly. Steroid risks include deterioration in DM, glucose toxicity, HONK and HHS. This may be avoided by a simple screening HbA1c, which could prompt a ‘safeguard algorithm’ for the patients including instruction in glucose monitoring. The ‘at risk’ cohort is identified, and a surveillance regime is implemented. </p...

Hyponatraemia, defined as a serum sodium concentration <135 nmol/l, is the most common disorder of body fluid and electrolyte balance encountered in clinical practice. Management of patients notoriously remains problematic and is associated with increased mortality, morbidity and length of hospital stay. The aim of this oral presentation will be to highlight and discuss new European guidelines in the diagnosis and treatment of patients with hyponatraemia. We will present p...

Introduction: Recent studies have shown that microRNA could serve as biomarkers in various types of cancer and other diseases. Aim: To reveal microRNA that differ in patients with Cushing’s diseases (CD) and Ectopic ACTH-syndrome (EAS) to form a specific panel for differential diagnosis of ACTH-dependent Cushing’s syndrome (CS).Materials and Methods: Plasma samples from both sinuses and cubital vein were drained during in...

Introduction: The inflammatory eye disease Graves’ orbitopathy (GO) is the main complication of Graves’ disease in patients. In previous studies we have shown that hypoxia and HIF-1 dependent pathways could play an important role in the pathogenic process of GO. Hypoxia is known to attract inflammatory cells and therefore maintains inflammation and recruitment of immune cells like macrophages (MQ). However, few is known about the specific contribution of MQ to the pr...

Background: Adrenocortical carcinoma (ACC) is a very rare and aggressive, endocrine malignancy with still limited treatment options. Approximately 60% of patients with ACC show endogenous glucocorticoid excess which could be one potential cause, why first clinical trials with immunotherapies, like immune checkpoint inhibitors, showed only modest results. Due to the lack of an ACC-specific antigen structure, other immunotherapeutic approaches, like specialized cancer treatments...

Introduction: This non-interventional study assesses real-life use and potential predictive parameters for lanreotide (LAN) in pts with either acromegaly (ACRO) or NET over a period of 24 months. We present a pre-specified interim analysis after first 6 months of therapy.Methods: The primary objective is to evaluate the long term treatment response under LAN and to correlate it with early changes of biochemical markers. The planned sample size is 152 (76...